Nusqe Spanton

Corvium, Inc. engages in the development of fist synthetic biology-based bacterial monitoring platform. Its product include Control-Pro, an EMP automation software that converts data into action. The company was founded by Bob Langer, Timothy Lu, Michael Koeris, Brett Chevalier, Micah Rosenbloom, Tanguy Chau, and James J. Collins in March 2009 and is headquartered in Woburnc, MA.

Sustainable Food Ventures LLC (Sustainable Food Ventures) is a venture capital firm founded in 2020 by Ryan Bethencourt and Mariliis Holm. The firm is headquartered in Durham, North Carolina.

Jellatech, Inc. is a company based in Raleigh, NC that develops innovative technologies to produce high quality, pure, animal-free collagen and gelatin. Jellatech's mission is to eliminate animals from the food system and create better ingredient products, starting with collagen and gelatin. Jellatech, Inc. was founded in 2020 by a group of innovators, dreamers, entrepreneurs and scientists, including Stephanie Michelsen and Kylie Hesp. Stephanie Michelsen has been the CEO since incorporation.

Tiamat Sciences Corp. is a biotech company based in Durham, NC. Tiamat Sciences is focused on reinventing recombinant proteins to fuel the next generation of biotech companies across various fields such as cellular agriculture, regenerative medicine, and vaccine production. The company provides animal-free recombinant proteins at a fraction of their cost with a reduced carbon footprint, using a new recombinant proteins production platform that utilizes transient expression, vertical farming, and computational design. The company's animal-free proteins derived from plants are affordable, scalable, and flexible, and they aim to remove animals from science and shape a more sustainable future. The company was founded in 2019 by Clément Carlier and France-Emmanuelle Adil, with France-Emmanuelle Adil serving as the CEO since then.

Venn Biosciences Corp. engages in developing an artificial intelligence-driven mass spectrometry discovery and validation platform. Its products include VENN Vista, a glycoproteomic analysis; OpenPIP software, a neural network for automated mass spectrometry peak integration; and cancer liquid biopsy. The company was founded by Lieza Denan, Aldo Carrascoso, Carlito B. Lebrilla, and Carolyn R. Bertozzi in June 2017 and is headquartered in South San Francisco, CA.

Wild Earth, Inc. manufactures and develops pet food. It offers Koji-based protein products for dogs and cats. The company was founded by Kristin Wuhrman, Abril Estrada, Ron Shigeta, and Ryan Bethencourt and is headquartered in Berkeley, CA.

Sosv Ltd (Sosv) is a multi-stage venture capital and accelerator firm founded by Sean O’Sullivan in 1994. The firm is headquartered in Ireland with an additional offices in Luxembourg, USA, Hong Kong and China.

Joyful Ventures Management Co. LLC (Joyful Ventures) is a venture capital firm founded in 2023. The firm is headquartered in West Hollywood, California.

Genescient Corp. operates as an American biotechnology company.

Vectr Ventures Ltd is a venture capital firm founded in 2009 by Arthur Law, Alan Chan, Jason Best, Mark Munoz and Adrian Chan. The firm is headquartered in Hong Kong.

Babel Ventures LLC (Babel Ventures) is a venture capital firm founded in 2017 by Barbara Minuzzi and Daniela Arruda. The firm is headquartered in San Francisco, California.

The American company was founded by Ryan Bethencourt.

Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA.

Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA.

Eligo Bioscience SA operates a micobiome engineering laboratory. The company uses synthetic biology and CRISPR and CAS technology to develop highly precise antimicrobials. The firm?s sequence-specific antimicrobials can therefore discriminate between close bacterial strains and selectively eradicate harmful bacteria from the microbiome while sparing the beneficial ones. The company was founded by Timothy Lu, Luciano Marraffini, David Bikard and Xavier Duportet in May 2014 and is headquartered in Paris, France.

Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA.

BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel.

Engine Biosciences Pte Ltd. develops novel combinations of genes and drugs for therapeutic and industrial purposes. The company was founded by Timothy Lu and Jeffrey Lu and is headquartered in Singapore.

ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field.

Nest.Bio Ventures (Nest.Bio) is a venture capital firm founded in 2017. The firm is headquartered in Cambridge, Massachusetts.

Indie Bio is a Venture Capital firm, a subsidiary of SOSV Ltd. founded in 2014 by Arvind Gupta. Indie Bio is headquartered in San Francisco.